Teva Pharms. USA, Inc. v. Sandoz, Inc.

Case Number: CLB0349

Date: 01.20.2015

Citation: No. 13-854 (U.S. Supreme Court)

When reviewing a district court’s findings of subsidiary factual matters made in the course of it construction of a patent claim, the Federal Circuit must apply a “clear err,” not a de novo, standard of review.

Download PDF Return to Case Law Briefs Main Page